OxLabs | Anti-Aging Sports Nutrition
OxLabs | Buy 5 Anti-Aging/Testosterone Boosting Formula Get 1 FREE
OxLabs | Buy Any 3 Bottles Get 10% Off

Posts Tagged ‘arthritis’

Chewing

Sunday, December 20th, 2009

Ever think about chewing your food properly? Read the following from Nutritionist Laura Rivkin:

We wait all day, thinking about what we are going to eat, yet when it comes time, we rush through the whole experience. We swallow our food practically whole, often while distracted, reading or watching television. In fact, we chew each bite an average of only eight times.

When it comes to increased health, it is not just what we eat, but how we eat. Digestion actually begins in the mouth, where food has its first chance to be broken down by the physical act of chewing and by its contact with the digestive enzymes contained in saliva. Saliva breaks down food in the mouth into simple sugars, creating a sweet taste. The more we chew, the sweeter our food becomes and the more we produce endorphins, the chemicals in our brains responsible for feeling good. Who thought that chewing could also help us reduce our cravings for sweets?

Chewing our food well maximizes assimilation, enabling  our bodies to absorb the nutrients in our food. It also increases our awareness of the food we are eating. When we are chewing well, we are more able to feel when we are full. In fact, chewing well can also eliminate digestive distress, promote healing and circulation, enhance our immunity, increase energy and endurance, improve skin health and stabilize weight. There are moving stories of concentration camp survivors who made it through the ordeal when others did not, due to chewing the meager amount of food they did have - up to 300 chews per bite of food!

Quiet can be confronting, with our constant mental diet of advertising, news, media, work and rush. Taking time with our meal, beginning with chewing, allows us to enjoy the whole experience of eating: the smells, the taste, the textures and our own anticipation. It helps us to give thanks, to show appreciation for the abundance we have in our lives and develops patience and self-control. For most of us 300 chews is pretty daunting and unrealistic. However, try chewing 30 chews per bite of food, and possibly, for the super challenge, to eat without reading or watching television. Rather than rushing through eating, what a shift it can be to savor and enjoy this thing we do all day, every day.

See Laura’s website at http://www.awholenewyou.org and put in your 30 chews!

Prolotherapy

Thursday, April 16th, 2009

OK, I have degenerated disks in my neck, bursitis and calcified tendons in both shoulders. The treatment options are limited, but I’m looking in Prolotherapy. Prolotherapy involves the injection of a proliferant (a mild irritant solution) that causes an inflammatory response. The intention is for the inflammation stimulate a healing process that results in the growth of new ligament and tendon tissue. The injections are typically targeted at the areas where the tendon and ligaments connect to the bone. This is the most critical part of the tendon/ligament structure, and this connection is the most common area for strains, tears, and the resulting pain. Anyone try this treatment? What were the results?

Glucosamine Sulfate Use and Delay of Progression of Knee Osteoarthritis

Sunday, February 22nd, 2009

I’ve had a lot of response regarding my previous post about Glucosamine clinical studies in Europe and the U.S. Here is a summery of one of the clinical studies that I was referencing, conducted at the Department of Medicine and Rheumatology, Charles University, Prague, Czech Republic in 2003: “Glucosamine was again tested for a period of three years against placebo in a placebo controlled double blind study, and the results were astoundingly in favor of Glucosamine. Placebo joint narrowing (How much “cushion” exists between the bones, more is better) was much more pronounced over Glucosamine, showing -.29 to .09 mm DETERIORATION with placebo versus a -.06 to .14 mm GROWTH with Glucosamine. Fewer patients with Glucosamine showed severe narrowings over placebo and the side effect profiles for both placebo and Glucosamine were the same”. “A drawback of many medicines to treat arthritis is that none of them are able to slow down or stop the progressive degeneration of the joints affected by arthritis. This study looked at the effect of glucosamine sulfate on the progression of arthritis over a 3 year period. Participants were separated into two groups, one to receive 1500 mg a day of glucosamine sulfate, the other to receive a placebo daily. The Lesquesne index and the WOMAC were administered to monitor pain feelings, and the joint space of the site of arthritis was monitored for progression. The joint space narrowing continued with the use of the placebo, but was stopped with the use of the glucosamine sulfate. The glucosamine sulfate also produced a greater alleviation of pain. As a long term treatment, glucosamine sulfate was effective at reducing pain of osteoarthritis and stopping the joint space narrowing. There were no side effects reported.”

U.S. vs. European Glucosamine Clinical Studies

Thursday, January 15th, 2009

I recently read about a clinical study in the U.S. that questioned the effectiveness of Glucosamine as a joint health treatment. I found this very hard to believe. This is a well-established product, and has provided real help for joint health, arthritis, and joint pain for millions of people, including myself for many years. Glucosamine has been studied for decades. I pulled out my file of clinical studies supporting the effectiveness of Glucosamine, going back to 1980, and noticed that many were done at prestigious Universities and Medical Centers in Europe (Italy, Germany, Czech Republic). Unlike here in the U.S., European doctors take botanical and non-prescription medicine very seriously. European physicians dispense herbal preparations on a regular basis for specific conditions and disease. What is considered “alternative medicine” in the U.S. is often a mainstream treatment in Europe. I wonder if a bias against non-FDA medications had an impact on the U.S. study.